Susan Morse
U.S. prices of several pre-filled insulin pens and vials will be up to 75% lower starting in January 2024.
Drug companies will pay rebates or face fines for raising prices faster than inflation.
MGMA and WEDI want the CMS provisions implemented before the current proposed date of January 1, 2026.
Fast-growing high deductible plans have changed the billing and patient experience, Cohen says.
Proposed changes to MA risk adjustment would result in an average payment cut of 3.7%, AHIP says in its own comment letter.
A representative from the DEA was invited to attend the special listening session.
Starling Physicians in Connecticut is being added to the VillageMD roster of primary care practices.
The tech stack digitizes the back office of the revenue cycle for faster payments, says CEO Stuart Hanson.
The drugmaker, the Biden administration and organizations are calling on other companies to do the same.
For those with private insurance, coverage for telehealth and other remote care services will vary by plan after the end of the PHE.